Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0650
0.00 (0.00%)
Feb 10, 2026, 1:01 PM AEST
Firebrick Pharma Revenue
In the fiscal year ending June 30, 2025, Firebrick Pharma had annual revenue of 515.51K AUD, down -81.26%. Firebrick Pharma had revenue of 318.44K in the half year ending June 30, 2025.
Revenue
515.51K
Revenue Growth
-81.26%
P/S Ratio
31.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 515.51K | -2.23M | -81.26% |
| Jun 30, 2024 | 2.75M | 2.73M | 12,096.48% |
| Jun 30, 2023 | 22.55K | -1.06M | -97.92% |
| Jun 30, 2022 | 1.08M | 661.35K | 156.72% |
| Jun 30, 2021 | 422.00K | -86.98K | -17.09% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Sigma Healthcare | 6.00B |
| Cochlear | 2.34B |
| Pro Medicus | 212.98M |
| Peak Processing | 15.49M |
| Neurotech International | 2.44M |
| OncoSil Medical | 1.54M |
| Intelicare Holdings | 956.74K |